Alzheimer’s Drug Discovery Foundation: Neuroimaging and CSF Biomarker

October 30, 2025

Deadline

02/23/2026

Amount

$600,000

Sponsor

Alzheimer's Drug Discovery Foundation

Research Area

Alzheimer's, Biomarkers

Funder Url

https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.alzdiscovery.org%2Fresearch-and-grants%2Ffunding-opportunities%2Fbiomarkers&data=05%7C02%7CVeronica.Alvarez%40med.usc.edu%7C8c0029369a894126d49308de1711c307%7Ca63249ac3e0b4a249e0cc90ab9891e30%7C1%7C0%7C638973562221834888%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=lIooWrCwL304vI0ixSgnN%2BaPwoMjSIHxuE4jh8soWkk%3D&reserved=0

If you are interested in the following opportunity, please contact Carole King at carole.king@med.usc.edu.

LOI due: February 23, 2026
Budget: $600,000 (no indirects)
Project period: one year

This RFP aims to further develop and validate established biomarkers with clear clinical value in Alzheimer’s disease and related dementias. It prioritizes biomarkers with a defined context of use, clear advantages over existing options, and a pathway to commercialization or clinical application, focusing on novel PET ligands, CSF biomarkers, innovative MRI approaches, and new measures of functional activity such as EEG.